- Traditional Chinese Medicine Analysis
- Phytochemistry and Biological Activities
- Cardiac, Anesthesia and Surgical Outcomes
- Traditional Chinese Medicine Studies
- Hemodynamic Monitoring and Therapy
- Natural product bioactivities and synthesis
- Cancer Immunotherapy and Biomarkers
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
- Enhanced Recovery After Surgery
- Metabolomics and Mass Spectrometry Studies
- Heavy Metals in Plants
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
- Renal function and acid-base balance
- Immune Cell Function and Interaction
- Plant chemical constituents analysis
- Cancer Mechanisms and Therapy
- Immune cells in cancer
- Breast Cancer Treatment Studies
- Essential Oils and Antimicrobial Activity
Guangxi Medical University
2023-2024
Sun Yat-sen Memorial Hospital
2023
Sun Yat-sen University
2023
First Affiliated Hospital of Anhui Medical University
2023
Anhui Medical University
2023
Theranostics (New Zealand)
2023
Gansu University of Traditional Chinese Medicine
2011-2012
National Institutes for Food and Drug Control
1990
Astragalus polysaccharide (APS) derived from A. membranaceus plays a crucial role in traditional Chinese medicine. These polysaccharides have shown antitumor effects and are considered safe. Thus, they become increasingly important cancer immunotherapy. APS can limit the spread of by influencing immune cells, promoting cell death, triggering autophagy, impacting tumor microenvironment. When used combination with other therapies, enhance treatment outcomes reduce toxicity side effects....
Abstract Background Sodium bicarbonated Ringer’s solution (BRS) has been gradually applied to clinic in recent years, while few clinical studies focused on the efficacy of BRS among elderly patients undergoing major surgery until now. This randomized controlled trial investigated lactate metabolism and outcomes sodium bicarbonate Ringer's vs. lactated (LRS) gastrointestinal surgery. Methods Sixty-two were enrolled this prospective, study. The participants assigned into group (BRS group) or...
Anlotinib is a tyrosine kinase inhibitor. It inhibits tumour growth by inhibiting the phosphorylation of angiogenesis-related receptors and attenuating expression related signals downstream this pathway. has shown good antitumour activity tolerability in patients with tumours, multitargeted inhibition angiogenesis does not lead to drug resistance due excessive bypass activation. Moreover, its superior that sunitinib, conventional Results from several clinical studies have indicated anlotinib...
In the era of anti-HER2 targeted therapy, potential clinical feasibility considering HER2-overexpressing breast cancer cases presenting with 1-3 positive axillary lymph nodes as low-risk, and thereby contemplating postoperative radiotherapy reduction, remains an important subject for in-depth examination. The aim this retrospective study was to evaluate effectiveness de-escalated in T1-2N1M0 patients receiving therapy. Specifically, omitting regional node irradiation (RNI) after...